{"transactions":[{"id":686454,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-14T16:04:25.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":37200,"price":10.32,"value":383904.0,"ownership":{"direct":true},"balance_after":482800,"source":{"system":"sec-edgar","filing":"0001834411-26-000008","document":"wk-form4_1786723463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000008/wk-form4_1786723463.xml","form_type":"4"}},{"id":750763,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2026-06-03T18:23:16.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8501849,"derivative":{"exercise_price":0.19,"expiration_date":"2026-06-15","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001834411-26-000006","document":"wk-form4_1780510993.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000006/wk-form4_1780510993.xml","form_type":"4"}},{"id":750762,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-06-03T18:23:16.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":true,"shares":250000,"price":0.19,"value":47500.0,"ownership":{"direct":true},"balance_after":445600,"source":{"system":"sec-edgar","filing":"0001834411-26-000006","document":"wk-form4_1780510993.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000006/wk-form4_1780510993.xml","form_type":"4"}},{"id":876478,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-02-27T19:48:34.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":42600,"price":3.42,"value":145692.0,"ownership":{"direct":true},"balance_after":195600,"source":{"system":"sec-edgar","filing":"0001834411-26-000004","document":"wk-form4_1772221711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000004/wk-form4_1772221711.xml","form_type":"4"}},{"id":949875,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:11:53.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":808898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8751849,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":808898},"source":{"system":"sec-edgar","filing":"0001834411-26-000002","document":"wk-form4_1767633111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000002/wk-form4_1767633111.xml","form_type":"4"}},{"id":1313307,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:37:59.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":1352054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":7942951,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":1352054},"source":{"system":"sec-edgar","filing":"0001628280-25-000233","document":"wk-form4_1735936673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000233/wk-form4_1735936673.xml","form_type":"4"}},{"id":1678893,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:18:59.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":770416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6590897,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":770416},"source":{"system":"sec-edgar","filing":"0001703057-24-000004","document":"wk-form4_1705447127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000004/wk-form4_1705447127.xml","form_type":"4"}},{"id":1875842,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-05-26T18:53:34.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":14500,"price":6.85,"value":99325.0,"ownership":{"direct":true},"balance_after":153000,"source":{"system":"sec-edgar","filing":"0001209191-23-032484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123032484/doc4.xml","form_type":"4"}},{"id":2077345,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2022-12-22T19:31:23.000Z","date":"2022-12-20","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5820481,"derivative":{"exercise_price":0.19,"expiration_date":"2026-06-15","underlying":"Common shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-062412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122062412/doc4.xml","form_type":"4"}},{"id":2077344,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2022-12-22T19:31:23.000Z","date":"2022-12-20","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a charitable donation of 50,000 common shares the reporting person donated on December 20, 2022."}],"balance_after":138500,"source":{"system":"sec-edgar","filing":"0001209191-22-062412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122062412/doc4.xml","form_type":"4"}},{"id":2077343,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-12-22T19:31:23.000Z","date":"2022-12-20","kind":"exercise","acquired":true,"shares":50000,"price":0.19,"value":9500.0,"ownership":{"direct":true},"balance_after":188500,"source":{"system":"sec-edgar","filing":"0001209191-22-062412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122062412/doc4.xml","form_type":"4"}},{"id":2095494,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:19:52.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":485661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first\ntranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5870481,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":485661},"source":{"system":"sec-edgar","filing":"0001209191-22-059568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059568/doc4.xml","form_type":"4"}},{"id":2269744,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-05-16T18:13:24.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":85000,"price":5.79,"value":492150.0,"ownership":{"direct":true},"balance_after":138500,"source":{"system":"sec-edgar","filing":"0001209191-22-029091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122029091/doc4.xml","form_type":"4"}},{"id":2412816,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-02-03T23:54:26.000Z","date":"2021-12-10","kind":"gift","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a charitable donation of 500,000 common shares the reporting person donated on December 10, 2021."}],"balance_after":53500,"source":{"system":"sec-edgar","filing":"0001209191-22-006960","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122006960/doc5.xml","form_type":"5"}},{"id":2476724,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options (right to buy)","published_at":"2021-12-10T22:00:14.000Z","date":"2021-12-10","kind":"exercise","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5384820,"derivative":{"exercise_price":0.32,"exercise_date":"2020-03-23","expiration_date":"2029-08-22","underlying":"Common Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-21-069084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121069084/doc4.xml","form_type":"4"}},{"id":2476723,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2021-12-10T22:00:14.000Z","date":"2021-12-10","kind":"exercise","acquired":true,"shares":500000,"price":0.32,"value":160000.0,"ownership":{"direct":true},"balance_after":553500,"source":{"system":"sec-edgar","filing":"0001209191-21-069084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121069084/doc4.xml","form_type":"4"}},{"id":2478520,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-12-09T22:58:32.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":406020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":5884820,"derivative":{"exercise_price":14.55,"expiration_date":"2031-12-07","underlying":"Common Shares","underlying_shares":406020},"source":{"system":"sec-edgar","filing":"0001209191-21-068849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121068849/doc4.xml","form_type":"4"}},{"id":2512211,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2021-11-15T11:05:16.000Z","date":"2021-11-11","kind":"purchase","acquired":true,"shares":14000,"price":14.61,"value":204540.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in two transactions at prices $14.67 and $14.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130959,"source":{"system":"sec-edgar","filing":"0001209191-21-064378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121064378/doc4.xml","form_type":"4"}},{"id":2512210,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2021-11-15T11:05:16.000Z","date":"2021-11-11","kind":"purchase","acquired":true,"shares":53500,"price":14.74,"value":788590.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in two transactions at prices $14.60 and $14.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53500,"source":{"system":"sec-edgar","filing":"0001209191-21-064378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121064378/doc4.xml","form_type":"4"}},{"id":2673263,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2021-06-10T21:00:48.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":1200000,"price":25.5,"value":30600000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-022988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022988/doc4.xml","form_type":"4"}},{"id":2674976,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-06-10T00:30:27.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2,000,000 shares subject to the option vested and became exercisable on March 23, 2020. The remaining 3,550,000 shares (the \"Remaining Shares\") subject to the option vest and become exercisable as follows: 25% of the Remaining Shares subject to such option vested and became exercisable on August 22, 2020 and the remainder of the Remaining Shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":4950000,"derivative":{"exercise_price":0.32,"expiration_date":"2029-08-22","underlying":"Common Shares","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000899243-21-022894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022894/doc4.xml","form_type":"4"}},{"id":2674975,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-06-10T00:30:27.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":300000,"derivative":{"exercise_price":0.19,"expiration_date":"2026-06-15","underlying":"Common Shares","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000899243-21-022894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022894/doc4.xml","form_type":"4"}},{"id":2674974,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2021-06-10T00:30:27.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":600000,"price":0.32,"value":192000.0,"ownership":{"direct":true},"balance_after":1200000,"source":{"system":"sec-edgar","filing":"0000899243-21-022894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022894/doc4.xml","form_type":"4"}},{"id":2674973,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2021-06-10T00:30:27.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":600000,"price":0.19,"value":114000.0,"ownership":{"direct":true},"balance_after":600000,"source":{"system":"sec-edgar","filing":"0000899243-21-022894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022894/doc4.xml","form_type":"4"}}]}